G R Dagenais
Overview
Explore the profile of G R Dagenais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Punthakee Z, Almeras N, Despres J, Dagenais G, Anand S, Hunt D, et al.
Diabet Med
. 2014 Jun;
31(9):1086-92.
PMID: 24890138
Aims: Thiazolidinediones reduce ectopic fat, increase adiponectin and reduce inflammatory adipokines, fatty acids and glucose in people with Type 2 diabetes. We aimed to measure these effects in people with...
2.
Anand S, Dagenais G, Mohan V, Diaz R, Probstfield J, Freeman R, et al.
Eur J Prev Cardiol
. 2011 May;
19(4):755-64.
PMID: 21551215
Aims: In an international prospective cohort study we assessed the relationship between glucose levels and incident cardiovascular events and death. Methods And Results: 18,990 men and women were screened for...
3.
St-Pierre A, Cantin B, Lamarche B, Auger D, Despres J, Dagenais G
Can J Cardiol
. 2010 Jan;
26(1):17-21.
PMID: 20101352
Background: The natural history of intermittent claudication, from its risk factors to its cardiovascular prognosis, has been reported in few prospective studies. Objective: To assess incident intermittent claudication, as well...
4.
Jackson D, White I, Kostis J, Wilson A, Folsom A, Wu K, et al.
Stat Med
. 2009 Feb;
28(8):1218-37.
PMID: 19222087
One difficulty in performing meta-analyses of observational cohort studies is that the availability of confounders may vary between cohorts, so that some cohorts provide fully adjusted analyses while others only...
5.
Dagenais G, Gerstein H, Holman R, Budaj A, Escalante A, Hedner T, et al.
Diabetes Care
. 2008 Feb;
31(5):1007-14.
PMID: 18268075
Objective: Impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) are risk factors for diabetes, cardiovascular disease (CVD), and kidney disease. We determined the effects of ramipril and rosiglitazone on...
6.
Danesh J, Erqou S, Walker M, Thompson S, Tipping R, Ford C, et al.
Eur J Epidemiol
. 2007 Sep;
22(12):839-69.
PMID: 17876711
Many long-term prospective studies have reported on associations of cardiovascular diseases with circulating lipid markers and/or inflammatory markers. Studies have not, however, generally been designed to provide reliable estimates under...
7.
8.
9.
Danesh J, Lewington S, Thompson S, Lowe G, Collins R, Kostis J, et al.
JAMA
. 2005 Oct;
294(14):1799-809.
PMID: 16219884
Context: Plasma fibrinogen levels may be associated with the risk of coronary heart disease (CHD) and stroke. Objective: To assess the relationships of fibrinogen levels with risk of major vascular...
10.
Gerstein H, Pogue J, Mann J, Lonn E, Dagenais G, McQueen M, et al.
Diabetologia
. 2005 Aug;
48(9):1749-55.
PMID: 16059716
Aims/hypothesis: Emerging data suggest that different indices of glycaemia are risk factors for clinical events. The aim of this analysis was to investigate the relationship between fasting plasma glucose or...